NCT03878706View on ClinicalTrials.gov

The Cardiovascular Effect of GLP-1 Agonist, SGLT2 Inhibitor and Their Combination

RecruitingOBSERVATIONAL
Enrollment

240

Participants

Timeline

Start Date

November 3, 2017

Primary Completion Date

December 31, 2026

Study Completion Date

June 30, 2027

Conditions
Diabetes Mellitus, Type 2
Trial Locations (1)

12462

RECRUITING

"Attikon University General Hospital", Athens

All Listed Sponsors
lead

University of Athens

OTHER